TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

IHE

iShares U.S. Pharmaceuticals ETF

NYSE ARCAETF
$100.96
+0.83%today

No SEC filings for this security

iShares U.S. Pharmaceuticals ETF is a foreign or OTC-listed security (NYSE ARCA) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$64.60 – $100.96
64.6052-week100.96
Volume
865K
1Y return
+56.82%
Beta
0.00

Price · 1Y

$100.96▲ +56.82%
over 1Y
L $64.38H $100.96

Recent news

market news →
Small-cap stocks enjoy their best first half in 35 years. Here's what's driving itBullish
cnbc.com· 2026-06-30
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?Bullish
finance.yahoo.com· 2026-06-29
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?Bullish
nasdaq.com· 2026-06-17
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF ReturnsBullish
finance.yahoo.com· 2026-06-10
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug MarketBullish
finance.yahoo.com· 2026-06-10
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next StrikeBullish
finance.yahoo.com· 2026-06-09
Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETFBullish
finance.yahoo.com· 2026-06-02
Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B BetBullish
finance.yahoo.com· 2026-05-29

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.